FDA and Its Role in Drug Development

JADPRO Live 2020 was honored to have Dr. Richard Pazdur, the Director of the Oncology Center of Excellence at the FDA, discuss recent changes to oncology drug development and the approval process, the roles of the advanced practitioner in the execution of clinical trials, and changes that have taken...

Descripción completa

Detalles Bibliográficos
Autor principal: Pazdur, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press LLC 2021
Materias:
Meeting Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8087239/
https://www.ncbi.nlm.nih.gov/pubmed/34084578
http://dx.doi.org/10.6004/jadpro.2021.12.3.15
_version_ 1783686631540129792
author Pazdur, Richard
author_facet Pazdur, Richard
author_sort Pazdur, Richard
collection PubMed
description JADPRO Live 2020 was honored to have Dr. Richard Pazdur, the Director of the Oncology Center of Excellence at the FDA, discuss recent changes to oncology drug development and the approval process, the roles of the advanced practitioner in the execution of clinical trials, and changes that have taken place as a result of the COVID-19 pandemic.
format Online
Article
Text
id pubmed-8087239
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Harborside Press LLC
record_format MEDLINE/PubMed
spelling pubmed-80872392021-06-02 FDA and Its Role in Drug Development Pazdur, Richard J Adv Pract Oncol Meeting Reports JADPRO Live 2020 was honored to have Dr. Richard Pazdur, the Director of the Oncology Center of Excellence at the FDA, discuss recent changes to oncology drug development and the approval process, the roles of the advanced practitioner in the execution of clinical trials, and changes that have taken place as a result of the COVID-19 pandemic. Harborside Press LLC 2021-04 2021-04-01 /pmc/articles/PMC8087239/ /pubmed/34084578 http://dx.doi.org/10.6004/jadpro.2021.12.3.15 Text en © 2021 Harborside™ https://creativecommons.org/licenses/by-nc-nd/3.0/This article is distributed under the terms of the Creative Commons Attribution Non-Commercial Non-Derivative License, which permits unrestricted non-commercial and non-derivative use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Meeting Reports
Pazdur, Richard
FDA and Its Role in Drug Development
title FDA and Its Role in Drug Development
title_full FDA and Its Role in Drug Development
title_fullStr FDA and Its Role in Drug Development
title_full_unstemmed FDA and Its Role in Drug Development
title_short FDA and Its Role in Drug Development
title_sort fda and its role in drug development
topic Meeting Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8087239/
https://www.ncbi.nlm.nih.gov/pubmed/34084578
http://dx.doi.org/10.6004/jadpro.2021.12.3.15
work_keys_str_mv AT pazdurrichard fdaanditsroleindrugdevelopment

Ejemplares similares